Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study
- PMID: 33673863
- PMCID: PMC7934982
- DOI: 10.1186/s40560-021-00538-8
Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study
Abstract
Purpose: We aimed to describe the use of high-flow nasal oxygen (HFNO) in patients with COVID-19 acute respiratory failure and factors associated with a shift to invasive mechanical ventilation.
Methods: This is a multicenter, observational study from a prospectively collected database of consecutive COVID-19 patients admitted to 36 Spanish and Andorran intensive care units (ICUs) who received HFNO on ICU admission during a 22-week period (March 12-August 13, 2020). Outcomes of interest were factors on the day of ICU admission associated with the need for endotracheal intubation. We used multivariable logistic regression and mixed effects models. A predictive model for endotracheal intubation in patients treated with HFNO was derived and internally validated.
Results: From a total of 259 patients initially treated with HFNO, 140 patients (54%) required invasive mechanical ventilation. Baseline non-respiratory Sequential Organ Failure Assessment (SOFA) score [odds ratio (OR) 1.78; 95% confidence interval (CI) 1.41-2.35], and the ROX index calculated as the ratio of partial pressure of arterial oxygen to inspired oxygen fraction divided by respiratory rate (OR 0.53; 95% CI: 0.37-0.72), and pH (OR 0.47; 95% CI: 0.24-0.86) were associated with intubation. Hospital site explained 1% of the variability in the likelihood of intubation after initial treatment with HFNO. A predictive model including non-respiratory SOFA score and the ROX index showed excellent performance (AUC 0.88, 95% CI 0.80-0.96).
Conclusions: Among adult critically ill patients with COVID-19 initially treated with HFNO, the SOFA score and the ROX index may help to identify patients with higher likelihood of intubation.
Keywords: COVID-19; High-flow nasal oxygen therapy; Hypoxemic respiratory failure; Invasive mechanical ventilation.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


References
Grants and funding
- (#CB06/06/1088; #PI16/00049; #PI18/01611; #PI19/00141/Instituto de Salud Carlos III
- (#CB06/06/1088; #PI16/00049; #PI18/01611; #PI19/00141/Instituto de Salud Carlos III
- Vanier Canada Graduate Scholarship/Canadian Institute of Health Research
- Vanier Canada Graduate Scholarship/Canadian Institute of Health Research
LinkOut - more resources
Full Text Sources
Other Literature Sources